DOCSLIB.ORG

Whitepaper Or Ascertained the Underlying Assumptions Relied FINAL DOCUMENT IS PRESENTED PRIOR to the DATE of the PUBLIC Upon by Such Sources

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text

Load more

grow.house DISCLAIMERS DISCLAIMER Third party sources generally state the information contained therein has been obtained from sources believed to be reliable; however, there THIS DOCUMENT PROVIDES AN INITIAL SUMMARY OF THE GROW are no assurances as to the accuracy or completeness of included TOKEN PROJECT. AS THE PROJECT PROCEEDS, THIS DOCUMENT information. Although the data is believed to be reliable, GROW has not IS EXPECTED TO EVOLVE OVER TIME. THE GROW TEAM MAY POST independently verified any of the data from third party sources referred MODIFICATIONS, REVISIONS AND/OR UPDATED DRAFTS UNTIL THE to in this whitepaper or ascertained the underlying assumptions relied FINAL DOCUMENT IS PRESENTED PRIOR TO THE DATE OF THE PUBLIC upon by such sources. TOKEN SALE. THIS WHITEPAPER SETS FORTH A DESCRIPTION OF THE PLANNED Please note that GROW is in the process of undertaking a legal and reg- USE OF THE GROW TOKEN. THIS IS BEING PROVIDED FOR INFORMA- ulatory analysis of the functionality of its GROW Tokens. Following the TION PURPOSES ONLY AND IS NOT A BINDING LEGAL AGREEMENT. conclusion of this analysis, GROW may decide to amend the intended THE GROW TOKEN SALE WILL BE GOVERNED BY SEPARATE TERMS & functionality of its GROW Tokens in order to ensure compliance with any CONDITIONS. IN THE EVENT OF A CONFLICT BETWEEN THE TERMS legal or regulatory requirements to which we are subject. In the event & CONDITIONS AND THIS WHITEPAPER, THE TERMS & CONDITIONS that GROW decides to amend the intended functionality of its GROW GOVERN. Tokens, GROW will update the relevant contents of this whitepaper and THIS WHITEPAPER IS NOT AN OFFERING DOCUMENT OR PROSPEC- upload the latest version of it to its website. TUS, AND IS NOT INTENDED TO PROVIDE THE BASIS OF ANY INVEST- GROW Tokens could be impacted by regulatory action, including poten- MENT DECISION OR CONTRACT. tial restrictions on the ownership, use, or possession of such tokens. Regulators or other circumstances may demand that the mechanics of LEGAL DISCLAIMER the GROW Tokens be altered, all or in part. GROW may revise mechan- ics to comply with regulatory requirements or other governmental or As of the date of publication of this whitepaper, GROW Tokens have no business obligations. Nevertheless, GROW believes they have taken all known uses, and are not permitted to be sold or otherwise traded on commercially reasonable steps to ensure that its planned mechanics third party exchanges. This whitepaper does not constitute advice nor a are proper and in compliance with currently considered regulations. recommendation by GROW Chain, Limited (“GROW” or “GROW Chain”), its officers, directors, managers, employees, agents, advisors or consultants, CAUTION REGARDING FORWARD-LOOKING STATEMENTS its affiliated entities and respective officers, directors, managers, employees, agents, advisors or consultants, or any other person to This whitepaper contains forward-looking statements or information any recipient of this document on the merits of the participation in the (collectively “forward-looking statements”) that relate to GROW‘s Token Sale. Participation in the Token Sale carries substantial risk and current expectations and views of future events. In some cases, these may involve special risks that could lead to a loss of all or a substantial forward-looking statements can be identified by words or phrases such portion of such an investment. Do not participate in the Token Sale as “may”, “will”, “expect”, “anticipate”, “aim”, “estimate”, “intend”, unless you are prepared to lose the entire amount you allocated to “plan”, “seek”, “believe”, “potential”, “continue”, “is/are likely to” or purchasing GROW Tokens. GROW Tokens should not be acquired for the negative of these terms, or other similar expressions intended to speculative or investment purposes with the expectation of making a identify forward-looking statements. GROW has based these for- profit or immediate re-sale. No promises of future performance or value ward-looking statements on its current expectations and projections are or will be made with respect to GROW Tokens, including no promise about future events and financial trends that it believes may affect its of inherent value, no promise of continuing payments, and no guarantee financial condition, results of operations, business strategy, financial that GROW Tokens will hold any particular value. Unless prospective needs, the results of the Token Sale or the value or price stability of the participants fully understand and accept the nature of GROW Tokens GROW Tokens. and the potential risks inherent in GROW Tokens, they should not In addition to statements relating to the matters set out here, this participate in the Token Sale. GROW Tokens are not being structured whitepaper contains forward-looking statements related to GROW’s or sold as securities. GROW Tokens are sold as a functional good and all proposed operating model. The model speaks to its objectives only, proceeds received by GROW may be spent freely by GROW, absent any and is not a forecast, projection or prediction of future results of oper- conditions set out in this whitepaper. This whitepaper is not a prospectus ations. or disclosure document and is not an offer to sell, nor the solicitation of Forward-looking statements are based on certain assumptions and any offer to buy any investment or financial instrument in any jurisdiction analysis made by GROW in light of its experience and perception of and should not be treated or relied upon as one. Written authorization historical trends, current conditions and expected future developments is required for distribution of any or all parts contained herein. and other factors it believes are appropriate, and are subject to risks and uncertainties. Although the forward-looking statements contained All information here that is forward looking is speculative in nature and in this whitepaper are based upon what GROW believes are reasonable may change in response to numerous outside forces, including tech- assumptions, these risks, uncertainties, assumptions, and other factors nological innovations, regulatory factors, and/or currency fluctuations, could cause GROW’s actual results, performance, achievements, including but not limited to the market value of cryptocurrencies. and experience to differ materially from its expectations expressed, implied, or perceived in forward-looking statements. Given such risks, This whitepaper is for information purposes only and is subject to prospective participants in the Token Sale should not place undue reli- change. GROW cannot guarantee the accuracy of the statements made ance on these forward-looking statements. or conclusions reached in this document. GROW does not make and GROW undertakes no obligation to update any forward-looking state- expressly disclaims all representations and warranties (whether ex- ment to reflect events or circumstances after the date of this whitepa- press or implied by statute or otherwise) whatsoever, including but not per. limited to: GROW’s business is subject to various laws and regulations in the coun- Any representations or warranties relating to merchantability, fitness tries where it operates or intends to operate. There is a risk that certain for a particular purpose, suitability, wage, title or non infringement; that activities of GROW may be deemed in violation of any such law or the contents of this document are accurate and free from any errors; regulation. Penalties for any such potential violation would be unknown. and that such contents do not infringe any third party rights. Additionally, changes in applicable laws or regulations or evolving GROW shall have no liability for damages of any kind arising out of the interpretations of existing law could, in certain circumstances, result in use, reference to or reliance on the contents of this document, even if increased compliance costs or capital expenditures, which could affect advised of the possibility of such damages. profitability, or impede GROW’s ability to carry on the business model and the GROW Tokens model proposed in this whitepaper. This whitepaper may include references to third party data and industry publications. GROW believes that this industry data is accurate and that RISK FACTORS its estimates and assumptions are reasonable; however, there are no For a description of the risk factors associated with the sale and pur- assurances as to the accuracy or completeness of this data. chase of Grow tokens, please visit: tbd 2 ©Grow House Ltd https://grow.house April 2021 ABSTRACT The medicinal cannabis production industry is well and truly on the radar of lawmakers in various jurisdic- tions. The plethora of positive scientific research regarding the health benefits of cannabis has made it -im possible for governments to ignore. Forward thinking jurisdictions have either granted permission for use of medicinal cannabis or they have commenced pilot programs permitting pharmaceutical companies to supply cannabis related products to patients. The objective of the Grow Token is to decentralize the cultivation of medicinal cannabis, and the payment and distribution of related products on the blockchain. Grow holders will have exclusive access to the already developed platform. The Grow community will be at the forefront of a fledgling industry which is on the cusp of receiving a massive shot of photosynthesis through the rollback of prohibition of cannabis for medicinal purposes in a wide number of global jurisdictions. THE GROW Decentralized
Recommended publications
  • Growing Practices and the Use of Potentially Harmful Chemical Additives Among a Sample of Small-Scale Cannabis Growers in Three Countries

    Growing Practices and the Use of Potentially Harmful Chemical Additives Among a Sample of Small-Scale Cannabis Growers in Three Countries

    Growing practices and the use of potentially harmful chemical additives among a sample of small-scale cannabis growers in three countries Simon LENTON1 Vibeke A. FRANK2 Monica J. BARRATT3, 1, 4 Gary R. POTTER5 Tom DECORTE6 1. National Drug Research Institute, Curtin University, Australia 2. Centre for Alcohol and Drug Research, Aarhus University, Denmark 3. Drug Policy Modelling Program, National Drug and Alcohol Research Centre, UNSW Australia. 4. Behaviours and Health Risks Program, Burnet Institute, Australia 5. Lancaster University Law School, UK 6. Institute for Social Drug Research (ISD), Ghent University, Belgium Contact details for Corresponding Author: Phone: +61 8 9266 1603 Fax: +61 8 9266 1611 Email: [email protected] Abstract Background: With the growth of legal cannabis markets there has been recognition of the adverse impacts of certain cannabis growing practices, notably, use of harmful chemicals. A major concern has been use of Plant Growth Regulators (PGRs) which limit plant size and stimulate bud production. These chemicals, many of which have been banned from food crops, have been found unlisted in cannabis growing nutrients sold online or in hydroponic stores. This study describes the cannabis growing practices used by small-scale recreational cannabis growers and specifically their self-reported use of chemicals. Methods: Web survey data from 1,722 current and recent cannabis growers in Australia, Denmark and the UK, who were asked about their cannabis growing practices, including the use of fertilizers and supplements. Results: Overall 44% of the sample reported using any chemical fertilizers, supplements or insecticides. Logistic regression indicated that the only unique predictor of the use of chemicals was growing hydroponically.
  • Environmental Risks and Opportunities in Cannabis Cultivation

    Environmental Risks and Opportunities in Cannabis Cultivation

    Environmental Risks and Opportunities in Cannabis Cultivation Michael O’Hare, BOTEC, UC Berkeley Peter Alstone, UC Berkeley Daniel L. Sanchez, UC Berkeley Final Revised Sept. 7, 2013 Table of Contents Executive Summary _______________________________________________________________________ 3 Introduction ________________________________________________________________________________ 4 Cannabis culture ___________________________________________________________________________ 4 Environmental consequences of cannabis production _________________________________ 5 Options for Environmental Protection _________________________________________________ 19 Recommendations _______________________________________________________________________ 23 Appendix 1: Figures from Mills 2012 __________________________________________________ 28 References _______________________________________________________________________________ 30 Sept. 7, 2013 FINAL Page 2 of 32 Executive Summary The most important environmental cost of marijuana production (cultivation of cannabis) in the legal Washington market is likely to stem from energy consumption for indoor, and to a lesser extent, greenhouse, growing. Nearly all of this energy is electricity used for lighting and ventilating, and the energy bill can amount to 1/3 of production costs. While the price of electricity provides growers a market signal for efficient production, it does not reflect the climate effect of greenhouse gas released by electricity production nor other “externalities”—the value of
  • Medical Marijuana – Risks and Violations

    Medical Marijuana – Risks and Violations

    Chris Beale, Chair Stephen Wamback, Vice-Chair Donald Erickson Meredith Neal Anna Petersen Brett Santhuff Dorian Waller City of Tacoma Scott Winship Planning Commission (vacant) PRESENTATIONS and HANDOUTS Regular Meeting on December 16, 2015 1. Environmental Action Plan (PowerPoint Slides; for Discussion Item E-1) 2. Marijuana Regulations (PowerPoint Slides; for Discussion Item E-2) 3. Planning Commission Recommendations from January 7, 2015 (Handout; for Discussion Item E-2) 4. Fire Codes and Standards: Denver’s Legalized Marijuana Industry and the Fire Code (Handout; for Discussion Item E-2) 5. The Hazards of Grow Houses (Handout; for Discussion Item E-2) 6. Legal Marijuana Grows – Growing a Problem (Handout; for Discussion Item E-2) 7. Revised Marijuana Retail Allocations (Handout; for Discussion Item E-2) The City of Tacoma does not discriminate on the basis of disability in any of its programs, activities, or services. To request this information in an alternative format or to request a reasonable accommodation, please contact the Planning and Development Services Department at (253) 591-5056 (voice) or (253) 591-5820 (TTY). 747 Market Street, Room 345 ❚ Tacoma, WA 98402 ❚ (253) 591-5682 ❚ FAX (253) 591-5433 ❚ http://www.cityoftacoma.org/planning The Tacoma Environmental Action Plan Kristin Lynett Office of Environmental Policy and Sustainability December 16th, 2015 Background • Need to update and expand our 2008 Climate Action Plan • Hired consultants in July • Created inter-department and agency Advisory Committee and Stakeholder meetings • Funding for Plan from ES, TPU, and general gov’t 2008 TPCHD, MPT, PC Tacoma 2025 Climate Action Plan Climate Risk Sust.
  • RECEIVED Subject: Fwd: Case 998-S-21 FEB O8 2021 External Email, Be Careful When Opening

    RECEIVED Subject: Fwd: Case 998-S-21 FEB O8 2021 External Email, Be Careful When Opening

    Susan Burgstrom From: John Hall Sent: Monday, February 8, 2021 8:51 AM To: Thaddeus Bates Cc: Susan Burgstrom Subject: RE: Case 998 -S-21 Good morning Mr. Bates. The 300 feet is measured from the proposed craft grower property to the nearest residence or to the property line if the property is zoned Residential. In this instance, there are two residences within 300 feet of the proposed craft grower property. The 300 feet is merely a threshold distance for when a craft grower must be approved by the County Board as a Special Use Permit but the 300 feet is not a prohibition distance. If no residence were located within 300 feet of the proposed craft grower then the proposed craft grower would be allowed without a County Board approved Special Use Permit. This will be the first craft grower Special Use Permit to be considered by the County Board. Please let us know if you have other questions. Susan Burgstrom is the planner working on this Case and I have copied this reply to Susan. Sincerely, John Hall Director Zoning Administrator Champaign County Department ofPlanning and Zoning Brookens Administrative Center 1776 East Washington Street Urbana IL 61802 Tel (217) 384-3708 Fax (217) (819-4021) From: Thaddeus Bates <[email protected]> Sent: Monday, February 8, 2021 7:45 AM To: John Hall <[email protected]> RECEIVED Subject: Fwd: Case 998-S-21 FEB O8 2021 External email, be careful when opening. CHAMPAIGN CO ;.:; & Z DEPARTMENT Good Morning John I reached out to several county board members and they have directed me to you for a few clarifications.
  • “Exploring the Problem of Domestic Marijuana Cultivation”

    “Exploring the Problem of Domestic Marijuana Cultivation”

    EXECUTIVE OFFICE OF THE PRESIDENT OFFICE OF NATIONAL DRUG CONTROL POLICY Washington, D.C. 20503 “Exploring the Problem of Domestic Marijuana Cultivation” Senate Caucus on International Narcotics Control Wednesday, December 7, 2011 2:30 p.m. 562 Dirksen Senate Office Building Written Statement of R. Gil Kerlikowske Director of National Drug Control Policy U.S. Senate Caucus on International Narcotics Control “Exploring the Problem of Domestic Marijuana Cultivation” Statement of R. Gil Kerlikowske Director, Office of National Drug Control Policy Executive Office of the President December 7, 2011 Chairman Feinstein, Co-Chairman Grassley, and distinguished members of the Caucus, thank you for this opportunity to testify today on the issue of marijuana cultivation on public and tribal lands. The Office of National Drug Control Policy (ONDCP) was established by Congress with the principal purpose of reducing illicit drug use, manufacturing, and trafficking; drug- related crime and violence; and drug-related health consequences. As a component of the Executive Office of the President, our office establishes policies, priorities, and objectives for the Nation’s drug control program. We also evaluate, coordinate, and oversee the international and domestic anti-drug efforts of executive branch agencies and ensure such efforts sustain and complement state and local anti-drug activities. As Director of National Drug Control Policy and chief advisor to the President on anti- drug efforts, I am charged with producing the National Drug Control Strategy, which directs the Nation’s drug policy efforts and establishes programs, a budget, and guidelines for cooperation among Federal, state, local, and tribal entities. My position allows me to raise public awareness and take action on drug issues affecting our Nation.
  • Literature Reviewon the Impacts of Cannabis Cultivation

    Literature Reviewon the Impacts of Cannabis Cultivation

    California Department of Food and Agriculture MEDICAL CANNABIS CULTIVATION PROGRAM Literature Review on the Impacts of Cannabis Cultivation California Department of Food and Agriculture MEDICAL CANNABIS CULTIVATION PROGRAM Literature Review on the Impacts of Cannabis Cultivation Prepared for: California Department of Food and Agriculture 1220 N Street Sacramento, California 95814 Contact: Amber Morris 916-900-5315 Prepared by: Horizon Water and Environment, LLC 180 Grand Ave, Suite 1405 Oakland, CA 94612 Contact: Michael Stevenson 510-986-1852 February 2017 TABLE OF CONTENTS Introduction .......................................................................................................................................... 1-1 1.1 Introduction ............................................................................................................................................ 1-1 1.2 Background ............................................................................................................................................. 1-1 1.3 Objectives .............................................................................................................................................. 1-2 1.4 Organization of this Document ....................................................................................................... 1-2 Methodology ......................................................................................................................................... 2-1 Description of Cannabis Cultivation ............................................................................................
  • He Legalization of Marijuana in Colorado: the Impact Vol

    He Legalization of Marijuana in Colorado: the Impact Vol

    PREPARED BY: ROCKY MOUNTAIN HIDTA STRATEGIC INTELLIGENCE UNIT The Legalization of Marijuana in Colorado: The Impact Vol. 5/October 2017 Table of Contents Executive Summary ............................................................................................ 1 Purpose ..................................................................................................................................1 Introduction .......................................................................................................... 7 Purpose ..................................................................................................................................7 The Debate ............................................................................................................................8 Background ...........................................................................................................................8 Preface ....................................................................................................................................8 Colorado’s History with Marijuana Legalization ...........................................................9 Medical Marijuana 2000-2008 .................................................................................................... 9 Medical Marijuana Commercialization and Expansion 2009-Present ............................... 10 Recreational Marijuana 2013-Present...................................................................................... 11 SECTION 1: Impaired

  • Cannabis: Carbon Footprint

    Energy Policy 46 (2012) 58–67 Contents lists available at SciVerse ScienceDirect Energy Policy journal homepage: www.elsevier.com/locate/enpol The carbon footprint of indoor Cannabis production Evan Mills Energy Associates, Box 1688, Mendocino, CA 95460, United States article info abstract Article history: The emergent industry of indoor Cannabis production – legal in some jurisdictions and illicit in others – Received 7 September 2011 utilizes highly energy intensive processes to control environmental conditions during cultivation. This Accepted 10 March 2012 article estimates the energy consumption for this practice in the United States at 1% of national Available online 17 April 2012 electricity use, or $6 billion each year. One average kilogram of final product is associated with 4600 kg Keywords: of carbon dioxide emissions to the atmosphere, or that of 3 million average U.S. cars when aggregated Energy across all national production. The practice of indoor cultivation is driven by criminalization, pursuit of Buildings security, pest and disease management, and the desire for greater process control and yields. Energy Horticulture analysts and policymakers have not previously addressed this use of energy. The unchecked growth of electricity demand in this sector confounds energy forecasts and obscures savings from energy efficiency programs and policies. While criminalization has contributed to the substantial energy intensity, legalization would not change the situation materially without ancillary efforts to manage energy use, provide consumer information via labeling, and other measures. Were product prices to fall as a result of legalization, indoor production using current practices could rapidly become non-viable. & 2012 Elsevier Ltd. All rights reserved. 1.
  • Q2 FY18 Financial Statements

    Q2 FY18 Financial Statements

    CANOPY GROWTH CORPORATION CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS (Unaudited) FOR THE THREE AND SIX MONTHS ENDED SEPTEMBER 30, 2017 AND 2016 (IN CANADIAN DOLLARS) CANOPY GROWTH CORPORATION TABLE OF CONTENTS Condensed interim consolidated statements of financial position.................................................................. 3 Condensed interim consolidated statements of operations............................................................................ 4 Condensed interim consolidated statements comprehensive loss................................................................. 5 Condensed interim consolidated statements of changes in shareholders’ equity.......................................... 6 Condensed interim consolidated statements of cash flows............................................................................ 8 Notes to the condensed interim consolidated financial statements................................................................ 9-32 CANOPY GROWTH CORPORATION CONDENSED INTERIM CONSOLIDATED STATEMENTS OF FINANCIAL POSITION UNAUDITED September 30, March 31, (Expressed in CDN $000's) 2017 2017 Assets Current assets Cash and cash equivalents (Note 19) $ 108,211 $ 101,800 Restricted short-term investments (Note 5) 668 550 Amounts receivable (Note 6) 6,782 5,815 Biological assets (Note 7) 23,496 14,725 Inventory (Note 7) 73,766 45,981 Prepaid expenses and other assets 5,319 3,735 218,242 172,606 Assets classified as held for sale (Note 8) - 6,180 218,242 178,786 Property, plant and equipment
  • New England Cannabis Corporation, Inc

    New England Cannabis Corporation, Inc

    Massachusetts Cannabis Control Commission Marijuana Product Manufacturer General Information: License Number: MP281466 Original Issued Date: 08/23/2019 Issued Date: 11/19/2020 Expiration Date: 11/21/2021 ABOUT THE MARIJUANA ESTABLISHMENT Business Legal Name: New England Cannabis Corporation, Inc. Phone Number: 617-716-6117 Email Address: [email protected] Business Address 1: 29 Everett Street Business Address 2: Business City: Holliston Business State: MA Business Zip Code: 01746 Mailing Address 1: 29 Everett Street Mailing Address 2: Mailing City: Holliston Mailing State: MA Mailing Zip Code: 01746 CERTIFIED DISADVANTAGED BUSINESS ENTERPRISES (DBES) Certifed Disadvantaged Business Enterprises (DBEs): Not a DBE PRIORITY APPLICANT Priority Applicant: yes Priority Applicant Type: RMD Priority Economic Empowerment Applicant Certifcation Number: RMD Priority Certifcation Number: RP201814 RMD INFORMATION Name of RMD: New England Cannabis Corporation Department of Public Health RMD Registration Number: Provisional Operational and Registration Status: Obtained Provisional Certifcate of Registration only To your knowledge, is the existing RMD certifcate of registration in good standing?: yes If no, describe the circumstances below: PERSONS WITH DIRECT OR INDIRECT AUTHORITY Person with Direct or Indirect Authority 1 Percentage Of Ownership: 100 Percentage Of Control: 100 Role: Executive / Ofcer Other Role: First Name: Kenneth Last Name: Stevens Sufx: Gender: Male User Defned Gender: Date generated: 12/03/2020 Page: 1 of 7 What is this person's
  • I Am Sgt Lyle Sinclair with the Bismarck Police, Bismarck ND. I Have Been an Officer with Bismarck Police Since 1993 and a K9 Handler Since 2003

    I Am Sgt Lyle Sinclair with the Bismarck Police, Bismarck ND. I Have Been an Officer with Bismarck Police Since 1993 and a K9 Handler Since 2003

    I am Sgt Lyle Sinclair with the Bismarck Police, Bismarck ND. I have been an officer with Bismarck Police since 1993 and a K9 handler since 2003. I am currently in charge of the K9 program for Bismarck Police. In 2016 when the Medical Marijuana was passed by popular vote I was in Gilbert AZ at K9 training. I was able to talk to AZ handlers to see how Medical MJ affected their K9 programs. It didn't affect them too much do too strict, well thought out laws. They treat it like alcohol for easy explanation. They investigate until they prove it is a crime or not. Recently I have heard concerns from handlers around the state as to what was going on in Colorado. I know a handler from Colorado Springs who agreed to come to Bismarck and discuss the effects of legal Marijuana sales to not only being a K9 handler but being an officer and a resident of Colorado. This officer, Officer Brian Kelly, gave a three hour power point and class to numerous officers of the state and allowed me to copy his power point. Below are some of the things I found most interesting/disturbing from his class: In 2000, Colorado became one of the first states to provide an affirmative defense to the limited possession and use of medical marijuana through the passage of Amendment 20. A decade later, the Colorado state legislature approved legislation licensing the commercial production and distribution of medical marijuana. In November 20121 access to marijuana was further advanced in the state with the passage of Amendment 64 (passed by 10 votes in El Paso County}, which legalized adult possession and use of retail marijuana.
  • Land Use Courthouse Annex • 2045 13Th Street • Boulder, Colorado 80302 • Tel: 303.441.3930 • Fax: 303.441.4856 Mailing Address: P.O

    Land Use Courthouse Annex • 2045 13Th Street • Boulder, Colorado 80302 • Tel: 303.441.3930 • Fax: 303.441.4856 Mailing Address: P.O

    Land Use Courthouse Annex • 2045 13th Street • Boulder, Colorado 80302 • Tel: 303.441.3930 • Fax: 303.441.4856 Mailing Address: P.O. Box 471 • Boulder, Colorado 80306 • www.bouldercounty.org BOULDER COUNTY PLANNING COMMISSION AGENDA ITEM # 4 May 18, 2016 Hearing Room, Third Floor Boulder County Courthouse PUBLIC HEARING Docket DC-16-0002: Proposed Boulder County Land Use Code Amendments to Article 4 and Article 18 to address the cultivation and processing of marijuana as a Residential Accessory Use STAFF PLANNER: Bryan Harding, Senior Planner SUMMARY: This docket was heard by the Boulder County Planning Commission on March 16, 2016. The hearing was tabled to April 20, 2016 to allow time for County staff to provide additional information to the Planning Commission regarding nine specific requests including: Summary of plant count limits and associated restrictions in other jurisdictions in Colorado Possibilities for allowing caregiver growing in excess of six plants in residential areas Additional information on proposed prohibitions on extraction technologies and methods, and whether such limitations are necessary Additional information regarding hazards and threats associated with marijuana cultivation in multi-family structures Additional information from health and safety stakeholders and the medical marijuana community Additional possibilities for enhanced enforcement of existing marijuana cultivation regulations Suggestions for implementation of a tiered approach to additional requirements or oversight that could be implemented if more than six plants per parcel are allowed Suggestions for education and outreach options to connect with and inform home growers Revised proposed language to clarify that processing of marijuana is limited only to those plants grown on a parcel.